jenny ho - genetic underlying leukemic transformation myeloproliferative neoplasms
Published 5 years ago • 166 plays • Length 20:17Download video MP4
Download video MP3
Similar videos
-
0:31
advancing theranostics - a vision for hope
-
1:33
meet gynecologic oncologist jolyn taylor, m.d.
-
1:18
investigating novel treatment options for bcg-unresponsive urothelial carcinoma
-
1:25
what are myeloproliferative neoplasms (mpns)?
-
37:04
the latest breakthroughs in immunotherapy for gu cancers
-
0:31
cancer interception unlocked - episode 1
-
4:38
at the nih clinical center: jamie hahn tests sample biopsies to identify genetic abnormalities
-
4:00
overview of urothelial carcinoma treatment landscape – the promise of immunotherapy
-
2:27
germline predisposition to myeloid malignancies: emerging research
-
0:52
the importance of evaluating heterogeneity in aml and how this may impact mrd assessment
-
1:02
elucidating the biology of upper tract urothelial cancer
-
0:59
how can precision medicine improve outcomes in gi oncology?
-
1:28
unmet needs in upper tract urothelial carcinoma
-
6:51
genitourinary cancer trials at anzup 2023: subdue-1 and zipup
-
1:00:44
research to improve genetic risk evaluation and management after diagnosis of cancer: ihpi seminar
-
1:49
early breast cancer: do we need chemotherapy in low genomic/high clinical risk (er /her2-)?
-
27:52
update: novel therapies beyond immunotherapy in gi cancers
-
3:02
novel treatment options for patients with metastatic, inoperable urothelial carcinomas
-
2:06
checkmate 901: nivolumab with gemcitabine-cisplatin in urothelial carcinoma